在患有子宫内膜癌的患者中,TMEM41A过度表达与预后不佳和免疫变化相关

Ke Shi1, Xiao-Li Liu2, Qiang Guo3

  • 1Department of Thoracic Surgery, Beilun District People's Hospital of Ningbo, Ningbo City, China.

PloS one
|July 21, 2023
PubMed
概括

跨膜蛋白41A (TMEM41A) 在子宫内膜癌 (EC) 中过度表达,并与预后不佳有关. TMEM41A可以作为EC的诊断生物标志物,与免疫微环境和RNA修饰相关.